Guardian Science Weekly

What’s behind the injectable peptide craze?

Loading player...
Grey-market injectable peptides – a category of substances with obscure, alphanumeric names such as BPC-157, GHK-Cu, or TB-500 – have developed a devoted following among biohackers and health optimisers. To understand how these unregulated substances have become mainstream and what they could be doing in our bodies, Madeleine Finlay hears from journalist Adrienne Matei and from Dr Anna Barnard, an associate professor at Imperial College London who researches peptides. Help support our independent journalism at theguardian.com/sciencepod
17 Mar English United Kingdom Science · Nature

Other recent episodes

Hantavirus explained: how does it spread and who is most at risk?

Three people have died after an outbreak of hantavirus onboard a cruise ship travelling from Argentina to Cape Verde. The World Health Organization says that a total of seven cases – two confirmed by laboratory testing and five suspected – have been identified on the cruise ship so far. They…
5 May 13 min

‘Historic breakthrough’: could the fossil fuel era be coming to an end?

The transition towards renewable energy received a boost last week when representatives from 57 countries met in Santa Marta, Colombia, for a world-first climate meeting aimed at bringing the fossil fuels era to an end. Madeleine Finlay hears from the Guardian’s global environment editor, Jon Watts, about how the landmark…
5 May 14 min

What is a food intolerance, and how do you know if you have one?

Social media is awash with content about food intolerances and the symptoms to look out for. But figuring out whether you actually have one, and what’s triggering it, is surprisingly difficult. One avenue people are gravitating towards is at-home testing. Madeleine Finlay sits down with health and lifestyle journalist Rebecca…
28 Apr 17 min
All episodes